|
|
|
|
|
SINGAPORE, Dec 30, 2022 - (ACN Newswire) - AcroMeta Group Ltd [SGX: 43F], an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology, pharmaceutical, research and academia sectors, has received a letter of award (LOA) for the design and build of laboratory and office space worth approximately S$6.1 million from a global clinical research organisation that helps companies conduct clinical development of drugs or medical devices (the Project).
The Project site work is commencing soon and a binding contract would be executed in due course. In the unlikely event that the execution of contract is not followed through, the Group is safeguarded as it would be entitled to claim a maximum value of approximately S$1.8 million for value of works performed.
Said Mr Lim Say Chin, Executive Chairman, "We are greatly encouraged that the Project involves a new customer in the biotechnology space. This speaks of the confidence that our customers have in our capabilities. We will continue to work hard towards delivering quality services, leveraging on our established track record and proven expertise as controlled environment specialist engineers."
The Project is expected to contribute positively to the earnings per share and net tangible assets per share of the Group for the current financial year ending 30 September 2023.
To the best of the Directors' knowledge, none of the Directors and controlling shareholders of the Company have any interests, direct or indirect, in the Project, other than through their respective shareholdings in the Company.
ACROMETA Group Ltd [SGX: 43F] [BIC: ACRO:SP] [RIC: ACRO.SI],
ACROMETA Group Ltd (previously ACROMEC Ltd) is an established specialist engineering services provider with more than 25 years of experience in the field of controlled environments. The Group has over the years acquired expertise in the design and construction of facilities requiring controlled environments such as laboratories, medical and sterile facilities and cleanrooms.
ACROMETA's business is divided into two main business segments: (i) Engineering, procurement, and construction services, specialising in architectural, and mechanical, electrical and process works within controlled environments; and (ii) Maintenance and repair services of facilities and equipment of controlled environments and their supporting infrastructure.
The Group mainly serves the healthcare, biotechnology, pharmaceutical, research and academia, and electronics sectors. ACROMETA counts amongst its customers, hospitals and medical centres, government agencies, research and development companies or agencies, research and development units of multinational corporations, tertiary educational institutions, pharmaceutical companies, semiconductor manufacturing companies, and multinational engineering companies. The company has been listed on the Catalist board of the Singapore Exchange since 2016. For more information, please visit www.acrometa.com.
Media and Analysts Contact:
ACROMETA Group Limited
Mr. Jerry Tan
Chief Financial Officer
Tel: +65 6415 0574
Email: jerry.tan@acromec.com
Waterbrooks Consultants Pte Ltd
Mr. Wayne Koo
Tel: +65 6958 8008 / +65 9338 8166
Email: wayne.koo@waterbrooks.com.sg
Email: query@waterbrooks.com.sg
This media release has been reviewed by the Company's sponsor, Evolve Capital Advisory Private Limited. It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the Exchange) and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document. The contact person for the Sponsor is Mr. Jerry Chua, 138 Robinson Road, #13-02 Oxley Tower, Singapore 068906, jerrychua@evolvecapitalasia.com.
Topic: Press release summary
Source: AcroMeta Group Limited
Sectors: Daily Finance, Funds & Equities, Construct, Engineering
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| AcroMeta Group Limited |
| Jan 26, 2024 11:00 HKT/SGT |
|
AcroMeta Receives Buy-Out Offer for its Controlled Environments Engineering Subsidiary |
| Dec 12, 2023 22:20 HKT/SGT |
|
Acrometa Signs Strategic Cooperation Framework Agreement to Develop Co-Working Lab Space in China |
| Nov 29, 2023 20:00 HKT/SGT |
|
Acrometa Posts Record Revenue of S$69.5 Million for FY2023, Continues to Pursue New Opportunities in Co-Working Lab Space Business |
| Nov 17, 2023 21:00 HKT/SGT |
|
Acrometa Subsidiary Signs Two MOUs to Develop Co-Working Laboratory Space Business in China |
| Nov 6, 2023 21:00 HKT/SGT |
|
Acrometa Group Signs MOU for Sand Concession, Opening New Business Opportunities in the Region |
| Oct 31, 2023 21:00 HKT/SGT |
|
Acrometa to Focus on Laboratory Construction and Co-Working Laboratory Space Business |
| Oct 6, 2023 17:30 HKT/SGT |
|
ACROMETA's Life Science Incubator (LSI) Signs Agreement with Ho Bee Land subsidiary to operate Co-Working Laboratory |
| Aug 15, 2023 20:00 HKT/SGT |
|
AcroMeta's Laboratory Construction Business Rides on Singapore's Pandemic Readiness Strategy |
| Apr 6, 2023 14:00 HKT/SGT |
|
Life Science Incubator Signs MOU with a strategic anchor tenant for its planned Brisbane Co-Working Laboratory Space Project |
| Mar 31, 2023 20:15 HKT/SGT |
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator |
| More news >> |
 |
|
|
|
